# Ultrasound Enthesitis Response in Psoriatic Arthritis

> **NCT03955861** · — · COMPLETED · sponsor: **Belfast Health and Social Care Trust** · enrollment: 80 (actual)

## Conditions studied

- Psoriatic Arthritis
- Psoriasis
- Enthesitis

## Interventions

- **BIOLOGICAL:** adalimumab
- **BIOLOGICAL:** Certolizumab
- **BIOLOGICAL:** Etanercept
- **BIOLOGICAL:** Golimumab
- **BIOLOGICAL:** Secukinumab

## Key facts

- **NCT ID:** NCT03955861
- **Lead sponsor:** Belfast Health and Social Care Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-14
- **Primary completion:** 2021-07-17
- **Final completion:** 2021-07-17
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2022-02-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03955861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03955861, "Ultrasound Enthesitis Response in Psoriatic Arthritis". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT03955861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*